CBD Pouches Market Size, Share & Trends Analysis Report By CBD Pouches Content (Up To 10mg, 10mg - 20mg), By Type (Flavored, Unflavored), By Distribution Channel (Online, Offline), By Region, And Segment Forecasts, 2022 - 2030

Report Overview

The global CBD pouches market size was valued at USD 112.6 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 18.5% from 2022 to 2030. CBD pouches are gaining traction among people as they are a safer alternative to smoking. Cannabidiol (CBD) is a non-psychoactive compound derived from the cannabis plant. CBD helps in alleviating anxiety, soothing pain and inflammation, and inducing relaxation. Further, according to a research report published in January 2022 by the University of Chicago, CBD may also help in blocking the COVID-19 virus from replication in humans.

The outbreak of COVID-19  resulted in strict lockdowns affecting the daily routine and consumer behavior almost in every industry. The shutdown of retail stores impacted the demand for non-essential products in the first two quarters of 2020. The market sales of CBD pouches were hampered remarkably initially owing to a massive slowdown in manufacturing and R&D activities and an increase in prices. However, the market witnessed significant growth from 2020 end due to investment by pharmaceutical firms in R&D for the development of plant-based medicine.

CBD pouches have proven to be effective in mitigating depression, anxiety, and stress, which increased significantly during the Covid-19 period. The rising incidence of depression among the population is expected to propel market growth. Sleep problems are considered a core symptom of depression. According to a research study published in Scientific Reports Journal in August 2019, sleep problems with depression increase an additional risk for perceived stress, anxiety, and a gradual decrease in health in the domains of self-care, mobility, cognition, pain, and interpersonal activities. CBD alternates serotonin levels in the brain as it contains a low level of THC and a high level of CBD, which help in alleviating depression. However, more research is needed to understand the benefits of CBD products for treating depression and other medical conditions including epilepsy, Crohn's disease, and Parkinson's disease.

Several product launches with different flavors will act as a stimulant for the market over the forecast period. For instance, in January 2020, Canndid announced the expansion of its CBD product ranges in the U.K. The product portfolio includes tinctures, gummies, oils, CBD pouches, tea, and coffee. Canndid also partnered with AllaboutCBD, one of the leading edibles manufacturers and CBD suppliers, for the expansion of CBD products beyond the U.K. The company aims to serve premium CBD pouches, with enhanced taste and quality. The growing number of distribution channels due to the penetration of new entrants in the market will boost the sales of the product.

The harmful effects of the source by which CBD pouches are made may limit the market growth. For instance, a heavy dosage of CBD can cause drowsiness, dry mouth, gastrointestinal issues, reduced appetite, and nausea. Furthermore, lack of awareness regarding CBD pouches and limited product penetration in developing countries owing to the legal framework will impede the market growth.

CBD Pouches Content Insights

The 10mg to 20mg segment accounted for the largest revenue share of over 45.0% in 2021. CBD dosage primarily depends on the symptoms and conditions that are being treated. It also depends on the endocannabinoid system, which is associated with the nervous system, behavior, motor control, emotions, and homeostasis. The majority of market players have introduced 20mg CBD per pouch as they are safe, provide relaxation, reduce stress, improve the sleep cycle, and optimize gut health.

CBD pouches below 10mg are primarily used for treating epilepsy (seizure disorder), anxiety, and muscle disorder, soothing pain and inflammation, and improving heart health. They are available in a variety of flavors and are a convenient way to begin with CBD as they cause minimal disruption to the daily routine. The others segment is anticipated to expand at a lucrative CAGR of 17.9% over the forecast period. Dosage over 20mg is ideal for treating sleep disorders, anxiety, and type 2 diabetes and providing relief from pain. Medical studies have revealed that people with schizophrenia and Parkinson’s disease have reported benefits after taking dosages of 40-1,280 mg per day for four weeks.

Type Insights

Flavored CBD pouches accounted for the largest revenue share of over 60.0% in 2021. These are made of a variety of ingredients, flavorings, and pouch material. Most common flavors include fruit, mint, and coffee. The major players are introducing unique flavors to attract consumers. For instance, in October 2020, Swedish Match announced its expansion in the CBD category by launching G.4 Green Flow, a hybrid product, with 8mg of nicotine and 8mg of CBD. The flavor is a blend of cucumber and lemon, designed to provide a cooling effect. Manufacturers also use natural sweeteners and herbs that promote tooth and gum health. 

Unflavored CBD pouches are anticipated to register a CAGR of 19.8% over the forecast period. These are natural as they do not contain artificial flavors or sweeteners and are beneficial for those who want to avoid sugar in their diet. A high-quality unflavored CBD pouch provides a sufficient cannabidiol release and a long-lasting effect to the user. However, unflavored pouches are harsh in taste, so to mask it, most companies are focusing on creating formulations that increase the benefits of CBD and enhance consumers’ experience. For instance, in February 2020, Cannadips CBD launched terpene-based CBD pouches, the Humboldt Collection in different flavors including Tangy Citrus, American Spice, Natural Mint, Tropical Mango, and Fresh Wintergreen. The Humboldt Collection consists of strain-based Terpene based profiles inside a CBD pouch.

Distribution Channel Insights

The offline segment accounted for the largest revenue share of over 50.0% in 2021. The CBD products are available through several distribution channels, such as medical stores and health stores. Dispensaries are the most preferred distribution channel among consumers owing to the easy and wide availability of these products. For instance, in March 2021, Cannadips Europe announced to offer its Tangy Citrus and Natural Mint flavored CBD pouches at COOP retail stores in Switzerland and online at COOP.ch. CBD pouches are available in small batch production at exclusive or selected retail stores through regional distributors’ networks. Popular drugstore chains such as CVS and Walgreens started selling CBD products in some stores. This, in turn, will increase the market demand for CBD pouches over the forecast period.

The online segment is anticipated to expand at a CAGR of 17.8% over the forecast period. Growing online presence and the convenience of purchasing online will further enhance the segment growth. The growth of online sales post Covid-19 pandemic, in tandem with the increased popularity of CBD among consumers aged 18 to 45 in general, will provide a positive market outlook for the online segment. However, startups and small merchants may face challenges in creating an online presence as CBD products are not legalized in many countries. Most market leaders in e-commerce and small-business payment processing such as Square, Stripe, and PayPal still won't allow small merchants to use their platforms to sell CBD or cannabis-related products.

Regional Insights

North America accounted for the largest revenue share of over 35.0% in 2021. Increasing sales of CBD pouches, by adult smokers in the region, is a key factor driving the demand for the product in the region. As per the Centers for Disease Control and Prevention report, 65.3 % of U.S. youth reported that they wanted to quit using all tobacco products in 2021. Quitting smoking can lead to temporary depression, anxiety, irritability, difficulty concentrating, increased appetite, and disrupted sleep patterns. FDA-approved therapies include CBD pouches, nicotine skin patches, gum, and lozenges that can provide relief and lessen withdrawal symptoms. This, in turn, will provide market opportunities for CBD pouches manufacturers in the region. Moreover, the Farm Bill passed at the end of 2018 legalized the commercial production of hemp in the U.S. Manufacturers, therefore, can grow industrial hemp with a license from the USDA or the state and then sell products containing hemp-derived CBD.

Europe is expected to expand at the fastest CAGR of 19.7% over the forecast period. Growing consumer awareness regarding the therapeutic effects of CBD pouches is expected to propel the demand for CBD pouches in the region. The presence of several players such as Cannadips Europe, Nicopods ehf., and The Snus Brothers with a strong foothold will further strengthen the regional market outlook. Key players are adopting partnership strategies to expand their footprint and widen their customer base in the region. For instance, in December 2021, Poko Group (UK) Ltd. partnered with Active CBD Manufacturing Ltd. to improve its product accessibility in the U.K. and reduce its final purchase cost of CBD pouches. Poko's CBD Pouches will be launched in the U.K. as a solution for CBD users, who are looking for a discreet and smoke-free solution to reduce anxiety and stress and improve the sleep cycle. The pouches come in eight different flavors including beery blast, berry breeze, mango crush, blackcurrant anise, strawberry haze, ice apple, glacial mint, and cherry orchard.

Key Companies & Market Share Insights

The market is consolidated and characterized by the presence of a few well-established players. Key players are adopting various strategies, including new product launches, expansion of product portfolios, partnerships, and mergers & acquisitions. For instance:

• In March 2022, SectrumLeaf Ltd., a company specializing in providing CBD-based products, partnered with Voon Innovation to launch smokeless cannabis, Voon hemp Snus pouches, that are nicotine-free. The ingredients used in Voon hemp Snus are vegan, natural, gluten and soy-free, and non GMOs. The hemp Snus can be used as a smokeless alternative for CBD users. Voon hemp pouches contain 20mg of hemp extract in each pouch and are available in four different flavors such as Pink Grape, Wintergreen, Snazzy Tangerine, and Cool Spearmint.

• In February 2020, Cannadips CBD launched terpene-based CBD pouches, the Humboldt Collection in different flavors.

• In January 2020, Lexaria Bioscience Corp., one of the global innovators in drug delivery platforms, signed an agreement with Cannadips CBD to provide its patented technology, DehydraTECH. The technology will help in enhancing the dipping experience through its high absorption technology that improves the consumer experience. 

Some prominent players in the global CBD pouches market include:

• METOLIUS HEMP COMPANY

• Canni Hemp Co.

• Canndid

• SNUSSIE.COM

• Cannadips CBD

• snushus.ch

• The Snus Brothers (SnusMe.eu)

• SnusMe.eu

• Nico’s Pouches

• Nicopods ehf. 

CBD Pouches Market Report Scope

Global CBD Pouches Market Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2017 to 2030. For the purpose of this study, Grand View Research has segmented the global CBD pouches market report on the basis of CBD pouches content, type, distribution channel, and region:

• CBD Pouches Content Outlook (Revenue, USD Million, 2017 - 2030)

  • Up to 10mg

  • 10mg - 20mg

  • Others

• Type Outlook (Revenue, USD Million, 2017 - 2030)

  • Flavored

  • Unflavored

• Distribution Channel Outlook (Revenue, USD Million, 2017 - 2030)

  • Online

  • Offline

• Regional Outlook (Revenue, USD Million, 2017 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • U.K.

    • France

    • Spain

  • Asia Pacific

    • China

    • Japan

    • South Korea

    • India

  • Central & South America

    • Brazil

    • Argentina

  • Middle East & Africa

    • UAE

    • Saudi Arabia